Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti–Programmed Death-Ligand 1 and Anti–Vascular Endothelial Growth Factor-A Antibodies

Gen Sugiyama; Kouki Nio; 丹尾 幸樹; Hikari Okada; 岡田 光; Akihiko Kida; Keisuke Sako; 迫 恵輔; Yasunori Iwata; 岩田 恭宜; Hideo Takayama; Yutaro Kawakami; Tomoyoshi Chiba; Kazuki Nagai; Saiho Sugimoto; Masaki Nishitani; Tomoyuki Hayashi; 林 智之; Hajime Takatori; 鷹取 元; Tetsuro Shimakami; 島上 哲朗; Masao Honda; 本多 政夫; Taro Yamashita; 山下 太郎

doi:https://doi.org/10.1016/j.gastha.2025.100778

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

インデックスリンク

インデックスツリー

アイテム

Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti–Programmed Death-Ligand 1 and Anti–Vascular Endothelial Growth Factor-A Antibodies

http://hdl.handle.net/2297/0002003748

名前 / ファイル	ライセンス	アクション
https://doi.org/10.1016/j.gastha.2025.100778

Item type

itemtype_001(1)

公開日

2025-12-08

タイトル

Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti–Programmed Death-Ligand 1 and Anti–Vascular Endothelial Growth Factor-A Antibodies

言語

作成者